Last reviewed · How we verify
calcium acetate and magnesium carbonate — Competitive Intelligence Brief
unknown
calcium acetate and magnesium carbonate
Hematology
Live · refreshed every 30 min
Target snapshot
calcium acetate and magnesium carbonate (calcium acetate and magnesium carbonate). Calcium acetate and magnesium carbonate bind to excess phosphate in the gastrointestinal tract, reducing its absorption into the bloodstream.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| calcium acetate and magnesium carbonate TARGET | calcium acetate and magnesium carbonate | unknown | calcium acetate and magnesium carbonate |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (calcium acetate and magnesium carbonate class)
- · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- calcium acetate and magnesium carbonate CI watch — RSS
- calcium acetate and magnesium carbonate CI watch — Atom
- calcium acetate and magnesium carbonate CI watch — JSON
- calcium acetate and magnesium carbonate alone — RSS
- Whole calcium acetate and magnesium carbonate class — RSS
Cite this brief
Drug Landscape (2026). calcium acetate and magnesium carbonate — Competitive Intelligence Brief. https://druglandscape.com/ci/calcium-acetate-and-magnesium-carbonate. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing